GLAND price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- GLAND
- MB Code
- MBEQU5224
- ISIN
- INE068V01023
- BSE code
- 543245
- Industry group
- Pharmaceuticals & Biotechnology
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 1742.79 Cr
- Net profit
- 366.68 Cr
- EPS
- 22.23
- YoY revenue
- +22.31%
Company documents
12 PDFs across 4 categories
Audited annual reports & financial statements
Earnings call transcripts & Q&A
Investor decks & strategy updates
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for GLAND
Gland Pharma jumped 11% after Q4 FY26 net profit rose 97% YoY to Rs 366.7 crore, revenue grew 22% to Rs 1,742.8 crore, and the board reco…
Gland Pharma rose 14.3% to a 52-week high after Q4 profit jumped 86.2% to ₹467.6 crore, revenue grew 22.3%, and Kotak upgraded it to 'add…
Gland Pharma shares surged 16% to a 52-week high after Q4 results, with Elara Capital and Motilal Oswal retaining Buy calls, boosting sen…
Gland Pharma surged after Q4 FY26 net profit rose 96.62% to Rs 366.7 crore and sales climbed 22.31% to Rs 1,742.8 crore, boosting investo…
EPS 22.23 vs est. 15.14
Beat estimates by 46.79%
Gland Pharma's consolidated net profit rose 96.57% in the March 2026 quarter; full-year profit climbed 47.07% to Rs 1,027.32 crore and sa…
Gland Pharma's Q4 FY26 net profit rose 96.62% to Rs 366.7 crore, while net sales grew 22.31% to Rs 1,742.8 crore versus Q4 FY25.
Gland Pharma declared a Rs 20/share dividend after Q4 profit doubled and margins expanded; EBITDA rose 48% to Rs 513 crore from Rs 347 cr…
Price returns
Historical performance
Technicals
Indicator consensus